Raymond James Financial Services Advisors’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $6.05M | Buy |
760,457
+78,895
| +12% | +$628K | 0.01% | 1124 |
|
|
2024
Q2 | $5.72M | Buy |
681,562
+56,097
| +9% | +$471K | 0.01% | 1099 |
|
|
2024
Q1 | $5.34M | Buy |
625,465
+2,913
| +0.5% | +$24.8K | 0.01% | 1099 |
|
|
2023
Q4 | $5.29M | Buy |
622,552
+71,845
| +13% | +$610K | 0.01% | 1058 |
|
|
2023
Q3 | $5.62M | Sell |
550,707
-30,529
| -5% | -$311K | 0.01% | 953 |
|
|
2023
Q2 | $7.56M | Buy |
581,236
+68,533
| +13% | +$892K | 0.01% | 826 |
|
|
2023
Q1 | $4.76M | Buy |
512,703
+194,893
| +61% | +$1.81M | 0.01% | 1023 |
|
|
2022
Q4 | $3.46M | Buy |
317,810
+280,832
| +759% | +$3.06M | 0.01% | 1152 |
|
|
2022
Q3 | $149K | Sell |
36,978
-267
| -0.7% | -$1.08K | ﹤0.01% | 2917 |
|
|
2022
Q2 | $272K | Sell |
37,245
-9,666
| -21% | -$70.6K | ﹤0.01% | 2656 |
|
|
2022
Q1 | $422K | Buy |
46,911
+8,282
| +21% | +$74.5K | ﹤0.01% | 2475 |
|
|
2021
Q4 | $436K | Sell |
38,629
-33,586
| -47% | -$379K | ﹤0.01% | 2462 |
|
|
2021
Q3 | $1.05M | Buy |
72,215
+12,053
| +20% | +$176K | ﹤0.01% | 1919 |
|
|
2021
Q2 | $980K | Sell |
60,162
-194
| -0.3% | -$3.16K | ﹤0.01% | 1953 |
|
|
2021
Q1 | $1.21M | Buy |
60,356
+3,400
| +6% | +$68.2K | ﹤0.01% | 1713 |
|
|
2020
Q4 | $1.17M | Buy |
56,956
+14,258
| +33% | +$293K | ﹤0.01% | 1608 |
|
|
2020
Q3 | $751K | Buy |
42,698
+31,365
| +277% | +$552K | ﹤0.01% | 1725 |
|
|
2020
Q2 | $192K | Sell |
11,333
-4,023
| -26% | -$68.2K | ﹤0.01% | 2505 |
|
|
2020
Q1 | $148K | Buy |
+15,356
| New | +$148K | ﹤0.01% | 2146 |
|